|

PD-1 Clinical Trials

3 actively recruiting trials

No change since May 2026

Also known as: immunotherapy

Pipeline

Phase 2: 3

Top Sponsors

  • Fudan University2
  • Sichuan Baili Pharmaceutical Co., Ltd.1

Indications

  • Cancer3
  • Urothelial Carcinoma1
  • Pancreatic Cancer1
  • Colorectal Cancer1

Other3 trials

A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Phase 2
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.